Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

Scotland is fortunate to have an abundance of world class higher education facilities within a relatively small geographic space. They innovate ...

CureVac NV (CVAC) reports a robust financial position with a significant licensing agreement with GSK, despite challenges in ...

Repirinast is the Company’s lead candidate for the treatment of CKD based on data showing it reduced fibrosis by 51% with statistical significance and showed an additive benefit to telmisartan in a ...

Algernon Pharmaceuticals (AGNPF) announces that it has received a notice of allowance from the European Patent Office, EPO, for patent ...

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

With nearly 800 cases adjudicated or pending thus far at the Unified Patent Court (UPC), a possible procedural gap has ...

After the European Commission abruptly withdrew its proposal on Standard Essential Patents (SEPs), several MEPs demand ...

Organizations that develop sophisticated approaches to IP risk management can protect their exit potential and create ...

The firm’s foray into Europe follows that of other US firms that have expanded their litigation footprints on the continent.